The moment I stepped into Gatz at the City of Dreams, Cinnamon Life, on Saturday, 20th September, I was immediately reminded ...
A researcher, Heikki Mäntysaari from the University of Jyväskylä (Finland), has been part of an international research group ...
Collectively, these findings provide the rationale and foundation for the innovative adaptive design of AdvanCell’s ongoing Phase 1b/2 TheraPb trial of ADVC001 (NCT05720130), the Company’s ...
AdvanCell, a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, today announced that it will present six ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results